McNeil implements corrective action plan
the McNeil Consumer Healthcare unit of Johnson & Johnson reported that it has taken steps to ensure that similar situations do not happen in the future.
in the NewsSalonCentric: One Beautiful Network Q4 2017 Rail/Intermodal Roundtable: Improvements apparent; work remains The State of the DC Voice Market Toyota Forklifts joins hurricane relief efforts CBRE data shows a decline in U.S. industrial real estate availability More News
In the wake of a product recall that included more than 50 million units of Tylenol arthritis products, St. Joseph's Aspirin, Motrin and other products, the McNeil Consumer Healthcare unit of Johnson & Johnson reported that it has taken steps to ensure that similar situations do not happen in the future. In a letter to the U.S. Food and Drug Administration, Peter Luther, McNeil president, wrote, “McNeil and Johnson & Johnson management are taking this issue very seriously and are committed to ensuring that McNeil implements all necessary corrective and preventive actions to improve the McNeil quality systems.” The letter also outlined key elements of the corrective action plan that includes enhancements to the quality system, organizational changes, and senior management oversight. For more, go to Modern's Web site, mmh.com/recall.
Subscribe to Modern Materials Handling Magazine!Subscribe today. It's FREE!
Find out what the world’s most innovative companies are doing to improve productivity in their plants and distribution centers.
Start your FREE subscription today!
This Month in Modern Materials Handling: Methodical steps into the future The Warehousing Big Picture: Business as Unusual View More From this Issue